Glioma stem-like cells (GSLCs) can be enriched from established cell lines or primary tumor tissues by using CD133 positive selection or generating neurospheres in serum-free media containing growth factors [12], [19]–[21]. This evidence concerns the gene PROM1 and neoplasm.